Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116283629A details a safe, one-pot synthesis of 5-amino-2-nitrobenzoic acid, eliminating heavy metal residues and reducing costs for diagnostic reagent manufacturing.
Patent CN112941116A details a novel enzymatic route for alpha-ketoglutarate calcium, offering superior purity and cost reduction in pharmaceutical manufacturing.
Novel synthesis of Levetiracetam avoiding toxic reagents. High purity API intermediate manufacturing with reduced environmental impact.
Patent CN109503436B reveals a metal-free route for difluoromethylthiolation. Discover cost-effective synthesis strategies for high-purity pharmaceutical intermediates.
Patent CN1210248C reveals a superior Group 4 catalyzed esterification process offering high purity cyclopropane intermediates with reduced side reactions and enhanced supply chain reliability for global manufacturers.
Patent CN105503565B reveals one-pot synthesis for Ketoprofen intermediate. Offers cost reduction and supply reliability for pharmaceutical manufacturing partners.
Patent CN109402212B reveals a novel fusion enzyme method for TUDCA production, offering significant cost reduction in bile acid manufacturing and reliable supply chain scalability.
Patent CN103387566B reveals a low-cost synthesis route for Dabigatran intermediates. Achieve high purity and supply chain stability with optimized crystallization processes.
Patent CN104498510A enables enzymatic synthesis of atorvastatin side chain with superior stereoselectivity and scalable fermentation processes for global supply chains.
Discover a cost-effective synthesis route for Edoxaban Tosylate intermediates. Enhance supply chain reliability and reduce manufacturing costs with our novel protocol.
Patent CN115786313B reveals enhanced nitrilase mutant for 2-chloronicotinic acid. Delivers significant yield improvements and green manufacturing advantages for supply chains.
Patent CN106083811A details enzymatic synthesis for high purity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107383139A reveals novel protecting groups for Obeticholic acid intermediates improving purification yield and supply chain stability for pharmaceutical manufacturing.
Patent CN100497338C reveals a biphasic hydrogenation method for carbapenem intermediates, offering significant cost reduction in API manufacturing and simplified purification.
Novel asymmetric transformation method for high-purity pharmaceutical intermediates. Reduces steps and enhances supply chain reliability for global procurement teams seeking efficient solutions.
Explore the advanced synthesis of ursolic acid chalcone and pyrazoline esters via patent CN101830961B. Discover cost-effective routes for high-purity oncology intermediates.
Novel boronic acid route eliminates toxic cyanide and palladium, offering cost-effective manufacturing for herbicide intermediates.
Novel patent CN108358783B details a safe, mild route for glutaric derivatives, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN108715881B reveals a dual-enzyme route for pregabalin intermediates. Achieve 99.5% e.e. and simplified processing for cost-effective API manufacturing.
Novel NHC catalyzed visible light synthesis method offers green efficient production for pharmaceutical intermediates supply chain.